The integration covers the company's full discovery pipeline, including phage display, screening, and cell sciences. By deploying Sapio’s Electronic Lab Notebook (ELN) and Laboratory Information Management System (LIMS), FairJourney Bio expects to eliminate manual transcription errors and spreadsheet-based tracking. Scientists will now feed data directly from laboratory instruments into a centralized, searchable registry, which the company estimates will reclaim up to 40% of staff time previously lost to administrative consolidation.
FairJourney Bio Standardizes Global Lab Operations on Sapio AI Platform
FairJourney Bio is replacing its fragmented, paper-based reporting systems with the Sapio Scientific AI Platform to manage antibody discovery across its international hubs. The transition aims to unify informatics across sites in Porto, Cambridge, and San Diego, allowing the company to automate data entry and accelerate client deliverables.
Central to this upgrade is Elain, an AI co-scientist embedded within the platform. Unlike external tools, Elain functions within the lab environment, allowing researchers to query experimental records using natural language and automate routine reporting. This capability provides a unified data structure that supports full traceability from initial target registration to final clone identification. For FairJourney Bio, which has completed over 1,400 discovery programs, this digital foundation provides the scalability required to support its growing operations in the US, UK, and Portugal.
Comments (0)
No comments yet. Be the first!